Introduction
============

Hemoglobinopathies are important inherited disorders with high prevalence in many tropical countries ([@b1]). In structurally abnormal hemoglobins, the following mechanisms can be invoked: single nucleotide base substitutions leading to amino acid replacement or chain termination variants; nucleotide deletions (or additions) leading to deletion and frameshift variants; and nonhomologous crossing over leading to the production of fused globin chains ([@b2]). A defect in the globin chain is the main cause of hemoglobinopathies. The molecular basis of the hemoglobinopathies, disorders characterized by the absence of, or decreased, synthesis of alpha globin or beta globin chains, is quite heterogeneous ([@b2]). The mutation in the gene coding for alpha globin or beta globin chains is the underlying pathogenesis of hemoglobinopathies ([@b1]). Clinical manifestations of these disorders vary from mild to severe presentations ([@b1]).

Predicting protein nanostructure and function is a great challenge in proteomics and structural genomics. Identifying the point vulnerable to mutation is a new trend in research on disorders at the genomic and proteomic level ([@b5]; [@b4]). Generally, disordered regions in proteins often contain short linear peptide motifs that are important for protein function. Identification of the peptide motifs in the amino acid sequence can give a good prediction of the weak linkages in a protein ([@b5]; [@b4]). A bioinformatics analysis was peformed to determine positions that tend to correspond with peptide motifs in the amino acid sequence of alpha globin and beta globin chains.

Materials and methods
=====================

Obtaining the amino acid sequence
---------------------------------

The database ExPASy ([@b3]) was used for searching the amino acid sequence of normal human alpha globin and beta globin chains. The derived sequences were then used to identify the weak linkage.

Identification of weak linkage in the globin chains
---------------------------------------------------

To identify the weak linkage in alpha globin and beta globin chains, a new bioinformatics tool, GlobPlot ([@b6]), was used. GlobPlot is a web service that allows the user to plot the tendency within the query protein for order/globularity and disorder ([@b6]). It successfully identifies interdomain segments containing linear motifs, and also apparently ordered regions that do not contain any recognized domains ([@b6]).

Results
=======

Twenty-two positions were identified for the alpha globin chain ([Figure 1](#fig1){ref-type="fig"}). The disorders were found at positions 3--8, 38--42, 46--51, and 75-79. Forty-six positions were identified for the beta globin chain ([Figure 2](#fig2){ref-type="fig"}). The disorders were found at positions 61--146.
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Discussion
==========

Structural aberration is believed to be the main underlying pathogenesis in hemoglobinopathy ([@b1]). Some disorders are described as a single substitution with other effects on the sequence frame; other disorders are mentioned as a frameshift ([@b1]). The mutations in globins can bring clinical manifestation in affected subjects. There are many reported mutations of globin and there are many undetermined ones. In the present study, an algorithm was used to identify the positions in the amino acid sequences of alpha globin and beta globin chains that can mutate.

Many positions were identified; some are known and others are newly discovered. Of interest, fewer positions were identified in alpha globin than in beta globin. More points with known mutations have been reported for beta globin than for alpha globin ([@b1]). The present study shows that weak linkages in the alpha globin and beta globin chains can be identified and can provide good information for predicting possible new mutations that can lead to new hemoglobin disorders.
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